Ladder Bio
Focus: Ladder Bio is a public biotech company founded in 2020 specializing in spiroligomers, a novel molecular scaffold for oncology applications. The company operates from Blue Bell, PA and is focused on advancing a differentiated pipeline in cancer therapeutics.
Profile data last refreshed 16h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Ladder Bio?
AI assessmentEarly-stage platform play with novel science, but minimal hiring activity and preclinical-stage pipeline present execution risk for career development.
Why Work Here
- Opportunity to work with novel spiroligomer platform technology at an early-stage public company with potential upside
- Oncology focus addresses large market opportunity with significant unmet need
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Ladder Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.